Firocoxib
Firocoxib.svg
Firocoxib molecule
Clinical data
Trade namesEquioxx, Previcox
AHFS/Drugs.comVeterinary Use
Veterinary Use
License data
Routes of
administration
By mouth
ATCvet code
Legal status
Legal status
Identifiers
  • 3-(Cyclopropylmethoxy)-5,5-dimethyl-4-(4-methylsulfonylphenyl)furan-2-one
CAS Number
PubChem CID
DrugBank
ChemSpider
UNII
KEGG
ChEBI
ChEMBL
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC17H20O5S
Molar mass336.40 g·mol−1
3D model (JSmol)
  • O=C2OC(C(=C2\OCC1CC1)\c3ccc(cc3)S(=O)(=O)C)(C)C
  • InChI=1S/C17H20O5S/c1-17(2)14(12-6-8-13(9-7-12)23(3,19)20)15(16(18)22-17)21-10-11-4-5-11/h6-9,11H,4-5,10H2,1-3H3 checkY
  • Key:FULAPETWGIGNMT-UHFFFAOYSA-N checkY
 ☒NcheckY (what is this?)  (verify)

Firocoxib sold under the brand names Equioxx and Previcox among others, is a nonsteroidal anti-inflammatory drug of the COX-2 inhibitor (coxib) class, approved for use in horses (Equioxx) and for use in dogs (Previcox).[1][3][6] Firocoxib is the first COX-2 inhibitor approved by the U.S. Food and Drug Administration for horses.[7] Firocoxib is not intended or approved for use in human medicine.[1][3][4][5][8]

Firocoxib was approved for veterinary use in the United States for dogs in July 2004,[9] and for horses in July 2016.[10] Firocoxib is available as a generic medication for horses[10] and for dogs.[9]

References

  1. ^ a b c "Equioxx- firocoxib tablet, chewable". DailyMed. 14 July 2020. Archived from the original on 3 August 2022. Retrieved 2 August 2022.
  2. ^ "Equioxx- firocoxib paste". DailyMed. 24 February 2022. Archived from the original on 3 August 2022. Retrieved 2 August 2022.
  3. ^ a b c "Previcox- firocoxib tablet, chewable". DailyMed. 23 July 2020. Archived from the original on 3 August 2022. Retrieved 2 August 2022.
  4. ^ a b "Equioxx EPAR". European Medicines Agency. Archived from the original on 25 April 2022. Retrieved 2 August 2022.
  5. ^ a b "Previcox EPAR". European Medicines Agency. Archived from the original on 31 July 2021. Retrieved 2 August 2022.
  6. ^ Rangel-Nava A, Ramírez-Uribe JM, Recillas-Morales S, Ibancovichi-Camarillo JA, Venebra-Muñoz A, Sánchez-Aparicio P (June 2019). "Pharmacological Regulation in the USA and Pharmacokinetics Parameters of Firocoxib, a Highly Selective Cox-2, by Pain Management in Horses". Journal of Equine Veterinary Science. 77: 36–42. doi:10.1016/j.jevs.2019.02.007. PMID 31133314. S2CID 86530623.
  7. ^ "New NSAID Equioxx (firocoxib) Approved by USEF". The Horse. 2 July 2007. Archived from the original on 18 May 2011. Retrieved 18 April 2008.
  8. ^ Equioxx Archived 21 December 2014 at the Wayback Machine, European Medicines Agency
  9. ^ a b "FDA Approves the First Generic Firocoxib Tablets for Dogs". U.S. Food and Drug Administration. 7 June 2022. Archived from the original on 3 August 2022. Retrieved 2 August 2022.
  10. ^ a b "FDA Approves the First Generic Firocoxib Tablets for Horses". U.S. Food and Drug Administration (FDA). 1 August 2022. Archived from the original on 3 August 2022. Retrieved 2 August 2022.